AF
AUPH icon

Allworth Financial’s Aurinia Pharmaceuticals AUPH Stock Holding History

Allworth Financial’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.1K Buy
3,307
+855
+35% +$13.7K ﹤0.01% 2382
2026
Q1 		$36.3K Buy
2,452
+1,698
+225% +$24.8K ﹤0.01% 2560
2025
Q4 		$12K Sell
754
-25
-3% -$354 ﹤0.01% 3146
2025
Q3 		$8.61K Buy
779
+162
+26% +$1.77K ﹤0.01% 3234
2025
Q2 		$5.23K Buy
617
+14
+2% +$112 ﹤0.01% 3237
2025
Q1 		$4.88K Hold
603
– – ﹤0.01% 2770
2024
Q4 		$4.66K Hold
603
– – ﹤0.01% 2798
2024
Q3 		$4.42K Buy
603
+63
+12% +$391 ﹤0.01% 2623
2024
Q2 		$3K Sell
540
-307
-36% -$1.62K ﹤0.01% 2740
2024
Q1 		$4.24K Sell
847
-32
-4% -$217 ﹤0.01% 2475
2023
Q4 		$7.9K Buy
879
+18
+2% +$148 ﹤0.01% 2079
2023
Q3 		$6.69K Buy
861
+14
+2% +$137 ﹤0.01% 1993
2023
Q2 		$8.2K Hold
847
– – ﹤0.01% 1923
2023
Q1 		$9.28K Buy
847
+447
+112% +$3.94K ﹤0.01% 1816
2022
Q4 		$1.73K Buy
400
+65
+19% +$377 ﹤0.01% 2292
2022
Q3 		$3K Buy
335
+235
+235% +$2.03K ﹤0.01% 2005
2022
Q2 		$1K Hold
100
– – ﹤0.01% 2086
2022
Q1 		$1K Hold
100
– – ﹤0.01% 1877
2021
Q4 		$2K Hold
100
– – ﹤0.01% 1703
2021
Q3 		$2K Hold
100
– – ﹤0.01% 1658
2021
Q2 		$1K Hold
100
– – ﹤0.01% 1442
2021
Q1 		$1K Sell
100
-100
-50% -$1.45K ﹤0.01% 1367
2020
Q4 		$3K Buy
+200
New +$2.91K ﹤0.01% 1064

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allworth Financial's AUPH Position: Q2 2026 in Review

Allworth Financial increased its Aurinia Pharmaceuticals (AUPH) stake by 35% in Q2 2026, buying an estimated $13.7K and bringing the position to 3,307 shares worth $56.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2382.

Allworth Financial first reported a position in AUPH in Q4 2020 and has held it in 23 quarters since. 281 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Allworth Financial held 3,307 shares of Aurinia Pharmaceuticals worth $56.1K as of Q2 2026.
  • Allworth Financial bought 855 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $13.7K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2382 holding.
  • Allworth Financial first reported a position in Aurinia Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • 281 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.